Prot #GX29176: A Phase III, Multicenter, Randomized, Double-masked, Sham-controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients with Geographic Atrophy Secondary to Age Related Macular Degeneration

Project: Research project

Project Details

StatusFinished
Effective start/end date4/1/169/27/20

Funding

  • INC Research, LLC (Prot #GX29176)
  • Genentech, Inc. (Prot #GX29176)